Cite
[Oral single-dose toxicity study of a new antineoplastic agent S-1, and its components, CDHP, and Oxo].
MLA
Hayashi, T., et al. “[Oral Single-Dose Toxicity Study of a New Antineoplastic Agent S-1, and Its Components, CDHP, and Oxo].” The Journal of Toxicological Sciences, vol. 21 Suppl 3, Nov. 1996, pp. 495–504. EBSCOhost, https://doi.org/10.2131/jts.21.supplementiii_495.
APA
Hayashi, T., Tanaka, G., Irimura, K., Hirota, T., & Ohmae, S. (1996). [Oral single-dose toxicity study of a new antineoplastic agent S-1, and its components, CDHP, and Oxo]. The Journal of Toxicological Sciences, 21 Suppl 3, 495–504. https://doi.org/10.2131/jts.21.supplementiii_495
Chicago
Hayashi, T, G Tanaka, K Irimura, T Hirota, and S Ohmae. 1996. “[Oral Single-Dose Toxicity Study of a New Antineoplastic Agent S-1, and Its Components, CDHP, and Oxo].” The Journal of Toxicological Sciences 21 Suppl 3 (November): 495–504. doi:10.2131/jts.21.supplementiii_495.